NM_000686.5:c.*1185G>T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000686.5(AGTR2):​c.*1185G>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0351 in 122,611 control chromosomes in the GnomAD database, including 81 homozygotes. There are 1,226 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.034 ( 74 hom., 1061 hem., cov: 22)
Exomes 𝑓: 0.044 ( 7 hom. 165 hem. )

Consequence

AGTR2
NM_000686.5 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.13

Publications

2 publications found
Variant links:
Genes affected
AGTR2 (HGNC:338): (angiotensin II receptor type 2) The protein encoded by this gene belongs to the G-protein coupled receptor 1 family, and functions as a receptor for angiotensin II. It is an intergral membrane protein that is highly expressed in fetus and in neonates, but scantily in adult tissues, except brain, adrenal medulla, and atretic ovary. This receptor has been shown to mediate programmed cell death and this apoptotic function may play an important role in developmental biology and pathophysiology. Mutations in this gene are been associated with X-linked cognitive disability. Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and SARS-CoV-2 infection results in down-regulation of angiotensin converting enzyme-2 (ACE2) receptors, the effects of which, triggers serious inflammatory lesions in the tissues involved, primarily in the lungs. The inflammatory reaction appears to be mediated by angiotensin II derivatives, including the angiotensin AT2 receptor which has been found to be upregulated in bronchoalveolar lavage samples from Coronavirus disease 2019 (COVID19) patients. [provided by RefSeq, Jul 2020]
AGTR2 Gene-Disease associations (from GenCC):
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • X-linked complex neurodevelopmental disorder
    Inheritance: XL Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.051 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AGTR2NM_000686.5 linkc.*1185G>T 3_prime_UTR_variant Exon 3 of 3 ENST00000371906.5 NP_000677.2 P50052
AGTR2NM_001385624.1 linkc.*1185G>T 3_prime_UTR_variant Exon 2 of 2 NP_001372553.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AGTR2ENST00000371906.5 linkc.*1185G>T 3_prime_UTR_variant Exon 3 of 3 1 NM_000686.5 ENSP00000360973.4 P50052

Frequencies

GnomAD3 genomes
AF:
0.0343
AC:
3814
AN:
111210
Hom.:
74
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.00629
Gnomad AMI
AF:
0.0102
Gnomad AMR
AF:
0.0326
Gnomad ASJ
AF:
0.0379
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0147
Gnomad FIN
AF:
0.0476
Gnomad MID
AF:
0.0380
Gnomad NFE
AF:
0.0527
Gnomad OTH
AF:
0.0379
GnomAD4 exome
AF:
0.0436
AC:
495
AN:
11347
Hom.:
7
Cov.:
0
AF XY:
0.0468
AC XY:
165
AN XY:
3527
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
3
American (AMR)
AF:
0.00
AC:
0
AN:
3
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.0437
AC:
489
AN:
11192
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2
European-Non Finnish (NFE)
AF:
0.0411
AC:
3
AN:
73
Other (OTH)
AF:
0.0423
AC:
3
AN:
71
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
19
38
57
76
95
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.0342
AC:
3809
AN:
111264
Hom.:
74
Cov.:
22
AF XY:
0.0317
AC XY:
1061
AN XY:
33510
show subpopulations
African (AFR)
AF:
0.00628
AC:
193
AN:
30739
American (AMR)
AF:
0.0326
AC:
339
AN:
10411
Ashkenazi Jewish (ASJ)
AF:
0.0379
AC:
100
AN:
2637
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3539
South Asian (SAS)
AF:
0.0143
AC:
38
AN:
2653
European-Finnish (FIN)
AF:
0.0476
AC:
283
AN:
5949
Middle Eastern (MID)
AF:
0.0372
AC:
8
AN:
215
European-Non Finnish (NFE)
AF:
0.0526
AC:
2784
AN:
52913
Other (OTH)
AF:
0.0374
AC:
57
AN:
1524
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
143
286
428
571
714
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0401
Hom.:
864
Bravo
AF:
0.0338

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.010
DANN
Benign
0.43
PhyloP100
-1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17231478; hg19: chrX-115305810; API